Domov › Kolorektálny karcinóm › Oklahoma › Oklahoma City
Klinické štúdie Kolorektálny karcinóm v meste Oklahoma City, OK
22 štúdií pre Kolorektálny karcinóm hľadá účastníkov v zariadeniach v meste Oklahoma City a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- University of Oklahoma Health Sciences Center, Oklahoma City
Family Communications After Genetic Testing
Prebieha náborVítaní zdravých dobrovoľníkov
- Mercy Hospital Oklahoma City, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- University of Oklahoma, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Mercy Hospital Oklahoma City, Oklahoma City
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Prebieha náborFáza 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Prebieha náborFáza 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Prebieha náborFáza 1/2
- Stephenson Cancer Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- University of Oklahoma, Oklahoma City
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Prebieha náborFáza 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Prebieha náborFáza 3
- Clinical Study Site, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Prebieha náborFáza 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
Prebieha nábor
- TSET Health Promotion Research Center, Oklahoma City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Stephenson Cancer Center, Oklahoma City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- SSM OKC Hightower Clinical, Oklahoma City
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Prebieha náborFáza 2
- Hightower Clinical, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Prebieha náborObservačná štúdia
- Mercy Hospital - OKC, Oklahoma City
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Prebieha náborFáza 1
- OU Stephenson Cancer Center, Oklahoma City
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Prebieha náborFáza 1
- OU Health Stephenson Cancer Center, Oklahoma City
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
- Mercy Hospital Oklahoma City, Oklahoma City
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Mercy Hospital Oklahoma City, Oklahoma City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Prebieha náborObservačná štúdia
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Štúdie Kolorektálny karcinóm v iných mestách
- Houston, TX102 štúdií
- New York City, NY78 štúdií
- Nashville, TN69 štúdií
- Boston, MA63 štúdií
- Los Angeles, CA59 štúdií
- Arlington, VA52 štúdií
- St. Louis, MO50 štúdií
- San Antonio, TX46 štúdií
- Philadelphia, PA44 štúdií
- Grand Rapids, MI40 štúdií
- Baldwin Park, CA37 štúdií
- Chicago, IL34 štúdií
Iné štúdie v Oklahoma City
- Nemalobunkový karcinóm pľúc28 štúdií
- Rakovina vaječníkov28 štúdií
- Rakovina endometria25 štúdií
- Rakovina prostaty21 štúdií
- Rakovina pľúc19 štúdií
- Rakovina prsníka17 štúdií
- Metastatická rakovina16 štúdií
- Rakovina (všetky typy)14 štúdií
- Akútna myeloidná leukémia14 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku13 štúdií
- Rakovina močového mechúra11 štúdií
- Rakovina pankreasu11 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.